ThermoMind is a cutting-edge technology company that is revolutionizing the healthcare industry by offering advanced thermal imaging solutions. Using the latest in thermal sensing technology and artificial intelligence, the company is dedicated to providing highly accurate and reliable imaging technologies that can help doctors and medical professionals make more informed decisions about patient care.

The company develops medical devices with customized, highly sensitive thermal sensing hardware and combines with sophisticated AI system to analyze thermal data and identify potential health issues in patients. Whether it's for early disease detection, real-time monitoring, or ongoing patient care, the company's imaging solutions offer unparalleled accuracy and reliability.
The current target of the company is transforming the way breast cancer is detected and diagnosed, by a next-generation non-contact and radiation-free screening modality for breast cancer detection. The core of the technology is the advanced AI analysis which is set to identify metabolic abnormalities within the breast indicating breast cancer.

The startup's screening modality is designed to be highly scalable, efficient, and cost-effective, making it accessible to a wide range of patients and healthcare providers. By eliminating the need for radiation and contact-based screening methods, the company's technology offers a safer and more comfortable screening experience for patients, while also reducing the risk of false positives and unnecessary biopsies.